A study of conjugation and drug elimination in the human neonate.
A J Cummings, A G Whitelaw
Index: Br. J. Clin. Pharmacol. 12(4) , 511-5, (1981)
Full Text: HTML
Abstract
1 An investigation has been made of the excretion of alpha-methyldopa, alpha-methyldopa sulphate, lorazepam and lorazepam glucuronide in the urine of neonates. 2 The rate of elimination of both the drugs in the newborn is slow compared with the adult rate, and apparent half-life being 3 to 4 times longer than the reported adult values. 3 The newborn appear able to readily metabolise alpha-methyldopa to alpha-methyldopa sulphate and to slowly conjugate lorazepam with glucuronic acid. alpha-Methyldopa tends to be conjugated to a greater extent and lorazepam to about the same or slightly lesser extent in the newborn than in adults. 4 It is postulated that elimination in the neonate is mainly controlled by the rate of renal excretion in the case of alpha-methyldopa and by the rate of conjugation in the case of lorazepam.
Related Compounds
Related Articles:
2002-03-01
[J. Forensic Sci. 47(2) , 427-8, (2002)]
2005-02-01
[Am. J. Kidney Dis. 45(2) , 360-71, (2005)]
Biotransformation and excretion of lorazepam in patients with chronic renal failure.
1976-12-01
[Br. J. Clin. Pharmacol. 3(6) , 1033-9, (1976)]
2006-01-01
[J. Sep. Sci. 29(1) , 153-63, (2006)]
2006-02-13
[J. Pharm. Biomed. Anal. 40(2) , 389-96, (2006)]